News Archives - Page 83 of 84 - El·lipse

Ferran Sanz is the director of the Research Programme on Biomedical Informatics (GRIB).

Research 18.10.2011

Ferran Sanz: “Habitual competitors are now working together to get better toxicity predictions”

Research 07.04.2011

David Searls: “Personalised medicine and Big Pharma need bioinformatics”

Manuel Pastor, group leader of the PharmacoInformatics group at the GRIB.

Scientific life 15.03.2011

Manuel Pastor: “I owe my scientific vocation to Spiderman”

The fruit fly was chosen to be the first multicellular organism to have its genome fully sequenced back in 2000 (Image by the Oregon State University at Flickr).

Public engagement 08.02.2011

Of flies and men

Sometimes DNA mutations cause subtle changes in how a protein works, but others lead to changes in the way a cell behaves (Image by Gerald, from Pixabay).

Public engagement 11.06.2010

SNPs: variation on a theme

Cristina Pujades is a scientist and researcher at the Department of Experimental and Health Sciences, Pompeu Fabra University (DCEXS-UPF).

Scientific life 20.03.2010

Cristina Pujades (DCEXS-UPF): “We need to change the immovable vision of universities and research centres”

The brain: the right hemisphere records visual and spatial memories, such as drawings, while the left hemisphere registers verbal memory, for example wors or numbers. Image from Pixabay.

Public engagement 16.03.2010

Studying memory

Model of the antipsychotic clozapine interacting with a set of receptors potentially involved in its pharmacological effect.

Public engagement 04.11.2009

Computer-assisted drug design

Thomas Graf is a group leader at the Centre for Genomic Regulation (CRG), one of the centres at the PRBB.

Scientific life 23.05.2009

Thomas Graf (CRG): “To be a successful scientist one needs to play and have fun”

Mara Dierssen is the head of the cellular and systems neurobiology research group at the CRG.

Scientific life 01.01.2009

Mara Dierssen (CRG): “Being a scientist is a way of life”

Ferran Sanz is the director of the IMIM-UPF Research Programme on Biomedical Informatics (GRIB).

Scientific life 18.09.2008

Ferran Sanz: “There should be no administrative frontiers on top of knowledge communities”

Drug development is a long and costly process. The clinical assays are the last part. Photo by freestocks.org on Unsplash

Research 14.04.2008

Clinical trials: the long path to the development of new drugs